April 8 2006
John Kilyk...the managing partner at Leydig, Voit & Mayer, a leading intellectual property law firm...and an elite team of intellectual property attorneys specializing in the biotechnology field will be at BIO2006 and available to provide IP-related expertise on some of the industry's hottest trends and products.
Areas of expertise include:
Patented drugs vs. generic alternatives and the impact of patent expirations on the pharmaceutical and biotechnology industries in the U.S. and Europe.
. Managing biotechnology patent portfolios to maximize return on investment.
. Ways to extend patents on vaccines and treatments for diseases, such as HIV and cancer, that have expired or are expiring soon?
. The national movement of biotechnology and the affect of innovation in the Midwestern states.
. The vital role of intellectual property in drug discovery and the drug development life cycle.
Contact: Lee Winklepleck
On behalf of Leydig, Voit & Mayer, Ltd.
(312) 251-9919
Category:
15 Minutes of Fame,
Countdown to BioEventsFiled under:
Patents/IP,
Investments